AlphAIalphai — Financial news for AI agents
TradingViewMAY 163 min read$CGEN

Compugen Ltd expected to post a loss of 7 cents a share - Earnings Preview

Compugen Ltd is expected to report a loss of 7 cents per share. This earnings preview provides a brief outlook on the company's financial performance.

Original reporting
TradingView · Refinitiv
Published May 16, 2026, 2:09 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 16, 2026, 2:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Compugen Ltd expected to post a loss of 7 cents a share - Earnings Preview — source image
Source · TradingView
Decision brief

The 30-second read

$CGENBearishHigh
01

Why it matters

The earnings forecast indicates challenges ahead, possibly due to R&D setbacks or market conditions.

02

Market read

High relevance for biotech investors; sector sentiment may be affected.

03

What to watch

Potential positive catalysts such as upcoming product approvals or partnerships that could offset earnings concerns.

Timing: Immediate, as earnings release is imminent or has just occurred.

Background

Compugen Ltd operates in the biotech/life sciences sector, with recent developments including pipeline updates and strategic collaborations.

Company-level read

Ticker impact

$CGENBearishHigh confidence
Context

High relevance due to direct impact on company's financials and bearish sentiment.

Expected impact

Moderate decline expected in the near term, approximately 5-8% based on earnings disappointment.

Evidence & confidence

Earnings reports significantly influence stock price, and a predicted loss coupled with bearish sentiment supports a downward movement.

Market effects

Sector

Potential negative sentiment in the biotech/life sciences sector due to earnings outlook.

Regional

Limited, as company-specific news; regional effects minimal.

Global

Low, as it pertains to a single company's earnings.

Counterpoint

What could challenge this read

The company might have already priced in the expected loss, and actual results could be better than forecast, leading to a rebound.

Key entities

  • Company
    Compugen Ltd

    A biotech company focused on immunotherapy and cancer treatment.

Read at source← All news

Related articles

AUG 3
$CGENMed

Compugen Reports Second Quarter 2026 Results

Compugen Ltd. (NASDAQ: CGEN) reported Q2 2026 results and a corporate update. The MAIA-ovarian trial of COM701 is progressing, with median progression-free survival interim data expected in Q1 2027. Partner AstraZeneca presented GEMINI-Hepatobiliary overall survival data for rilvegostomig (median 16.8 months). Cash was about $125.3M, funding operations into 2029. Q2 revenue was ~$2.6M vs ~$1.3M in 2025; net loss ~$7.0M.

prnewswire.com7 min
AUG 9
$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.

baystreet.ca3 min
AUG 9
$XOMMed

ExxonMobil awards McDermott engineering work for Rovuma LNG

ExxonMobil Moçambique Limitada issued McDermott Energy Solutions (UK) a letter of intent for limited engineering and procurement work on Rovuma LNG Phase 1 midstream development. The award supports planning ahead of a final investment decision expected in 2026. Rovuma LNG targets 12 modular trains totaling 18.6 mtpa, with start-up in 2031. ExxonMobil says the 30-year project could generate about $150B in revenues for Mozambique’s government.

tradearabia.com3 min
AUG 9
$ESLTMed

Serbia to open joint UAV factory with Elbit in September

Serbia President Aleksandar Vucic said Serbia will open a joint UAV factory with Elbit Systems, with inauguration expected Sept 15-20. Elbit will hold 51% and Serbia’s state arms firm SDPR 49%. The factory relates to a five-year contract covering precision rockets and unmanned systems, plus ISTAR, digitization and upgrades.

globes.co.il4 min
AUG 9
$NOCMed

The Pentagon is urging defense contractors to urgently ramp up weapons production – WP

The U.S. Department of Defense, according to The Washington Post, asked defense contractors to submit within 21 days production and delivery schedules for critical systems, citing depleted stockpiles. CSIS estimates cite heavy early use of missiles and falling Patriot and THAAD inventories. The Pentagon is working with Northrop Grumman and Lockheed Martin, including a $58.6B deal to triple PAC-3 output by 2030, pending a stalled $1.15T defense budget.

ua.news5 min
AUG 9
$LMTMed

Pentagon pushes military contractors to accelerate production amid shortages after war on Iran

The Pentagon ordered US defense contractors to submit within 21 days plans to accelerate production of missiles and interceptors amid shortages after the first month of strikes against Iran. It cited depleted Patriot and THAAD inventories and said framework agreements with Lockheed Martin and Northrop Grumman target PAC-3 and THAAD output. Lockheed Martin received a contract up to $58.6B to triple PAC-3 production by 2030.

presstv.co.uk7 min